Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Martine F Roussel
Affiliation
St. Jude Children's Research Hospital
ORCID
Career Start Year
1977
Papers
232
H Index
87
Expertise
CM4AI Collaborator
Antoine Forget (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36318650
Combination of Ribociclib with BET-Bromodomain and PI3K/mTOR Inhibitors for Medulloblastoma Treatment In Vitro and In Vivo.
Mol Cancer Ther
2023
37910601
Intrathecal delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid for the treatment of metastatic medulloblastoma.
Sci Transl Med
2023
37971169
CAR T-cell Design-dependent Remodeling of the Brain Tumor Immune Microenvironment Modulates Tumor-associated Macrophages and Anti-glioma Activity.
Cancer Res Commun
2023
37020038
Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities.
Oncogene
2023
37183219
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells.
J Neurooncol
2023
37333156
CAR T-cell design dependent remodeling of the brain tumor immune microenvironment identify macrophages as key players that inhibit or promote anti-tumor activity.
Res Sq
2023
36786675
Targeting protein folding in N-Myc-driven medulloblastoma.
Mol Oncol
2023
36765089
Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability.
Nat Commun
2023
36898329
From PROTAC to inhibitor: Structure-guided discovery of potent and orally bioavailable BET inhibitors.
Eur J Med Chem
2023
35798383
Primary cilia control translation and the cell cycle in medulloblastoma.
Genes Dev
2022
35709750
Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma.
Mol Cancer Ther
2022
33320196
Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery.
Neuro Oncol
2021
33744463
LC-MS/MS method for quantitation of gemcitabine and its metabolite 2',2'-difluoro-2'-deoxyuridine in mouse plasma and brain tissue: Application to a preclinical pharmacokinetic study.
J Pharm Biomed Anal
2021
33629064
Thrombospondin-1 mimetics are promising novel therapeutics for MYC-associated medulloblastoma.
Neurooncol Adv
2021
33509943
Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers.
Cancer Res
2021
34614283
Phenyl-Glutarimides: Alternative Cereblon Binders for the Design of PROTACs.
Angew Chem Int Ed Engl
2021
34042448
Identification of Potent, Selective, and Orally Bioavailable Small-Molecule GSPT1/2 Degraders from a Focused Library of Cereblon Modulators.
J Med Chem
2021
33963961
Medulloblastoma recurrence and metastatic spread are independent of colony-stimulating factor 1 receptor signaling and macrophage survival.
J Neurooncol
2021
34215733
Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma.
Nat Commun
2021
33472956
Small-molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma.
Sci Transl Med
2021
32519082
Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource.
Acta Neuropathol
2020
31788908
Modeling pediatric medulloblastoma.
Brain Pathol
2020
31669383
CNS penetration and pharmacodynamics of the CHK1 inhibitor prexasertib in a mouse Group 3 medulloblastoma model.
Eur J Pharm Sci
2020
31948942
An ABC Transporter Drives Medulloblastoma Pathogenesis by Regulating Sonic Hedgehog Signaling.
Cancer Res
2020
31948065
Preclinical Models of Craniospinal Irradiation for Medulloblastoma.
Cancers (Basel)
2020
30366006
Preclinical Modeling of Image-Guided Craniospinal Irradiation for Very-High-Risk Medulloblastoma.
Int J Radiat Oncol Biol Phys
2019
31399583
MYC competes with MiT/TFE in regulating lysosomal biogenesis and autophagy through an epigenetic rheostat.
Nat Commun
2019
31251562
Ventromorphins: A New Class of Small Molecule Activators of the Canonical BMP Signaling Pathway.
ACS Chem Biol
2019
31417200
Women in cancer research.
Nat Rev Cancer
2019
30885981
Myc and Loss of p53 Cooperate to Drive Formation of Choroid Plexus Carcinoma.
Cancer Res
2019
30487124
A CK1α Activator Penetrates the Brain and Shows Efficacy Against Drug-resistant Metastatic Medulloblastoma.
Clin Cancer Res
2019
29339161
A new genetically engineered mouse model of choroid plexus carcinoma.
Biochem Biophys Res Commun
2018
29909548
Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas.
Acta Neuropathol
2018
29880921
Mouse medulloblastoma driven by CRISPR activation of cellular Myc.
Sci Rep
2018
29698863
Development and validation of a sensitive LC MS/MS method for the measurement of the checkpoint kinase 1 inhibitor prexasertib and its application in a cerebral microdialysis study.
J Pharm Biomed Anal
2018
29774125
The critical role that STAT3 plays in glioma-initiating cells: STAT3 addiction in glioma.
Oncotarget
2018
29514916
CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss.
J Exp Med
2018
29178021
Epigenetic Drivers in Pediatric Medulloblastoma.
Cerebellum
2018
29301833
Establishing a Preclinical Multidisciplinary Board for Brain Tumors.
Clin Cancer Res
2018
29170024
Exploiting a water network to achieve enthalpy-driven, bromodomain-selective BET inhibitors.
Bioorg Med Chem
2018
28787124
Ventromorphins: A New Class of Small Molecule Activators of the Canonical BMP Signaling Pathway.
ACS Chem Biol
2017
28329683
Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma.
Cell Rep
2017
29103956
mTORC1-Mediated Inhibition of 4EBP1 Is Essential for Hedgehog Signaling-Driven Translation and Medulloblastoma.
Dev Cell
2017
29029386
Exome sequencing analysis of murine medulloblastoma models identifies WDR11 as a potential tumor suppressor in Group 3 tumors.
Oncotarget
2017
28538182
Targeting Metabolic Reprogramming by Influenza Infection for Therapeutic Intervention.
Cell Rep
2017
28504719
Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells.
Oncogene
2017
28768907
Upregulated heme biosynthesis, an exploitable vulnerability in MYCN-driven leukemogenesis.
JCI Insight
2017
27050100
Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype.
Cancer Cell
2016
26518542
Preclinical studies of 5-fluoro-2'-deoxycytidine and tetrahydrouridine in pediatric brain tumors.
J Neurooncol
2016
27178982
Zeb1 controls neuron differentiation and germinal zone exit by a mesenchymal-epithelial-like transition.
Elife
2016
1 - 50 of 232
Column Actions
Search
Recommended Authors
Genevi??ve Lavoie
Institute for Research in Immunology and Cancer (IRIC)
Career Start Year
2004
Number of shared co-authors
0
Qingxia Wei
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year
2000
Number of shared co-authors
3
Wendy Dubois
Center for Cancer Research, National Cancer Institute
Career Start Year
2000
Number of shared co-authors
0
Yaoqi Alan Wang
The University of Texas MD Anderson Cancer Center
Career Start Year
1997
Number of shared co-authors
1
Sanja Pajovic
Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children
Career Start Year
1993
Number of shared co-authors
16
Julien Sage
Department of Pediatrics Stanford University Stanford California USA.
Career Start Year
1993
Number of shared co-authors
7
Celio Pouponnot
Institut Curie
Career Start Year
1993
Number of shared co-authors
22
Andrei Goga
University of California San Francisco
Career Start Year
1993
Number of shared co-authors
4
Jan Willem Voncken
Maastricht University
Career Start Year
1992
Number of shared co-authors
0
James DeGregori
University of Colorado Anschutz Medical Campus
Career Start Year
1991
Number of shared co-authors
1
Aykut Uren
Georgetown University Medical Center
Career Start Year
1991
Number of shared co-authors
4
Rod Bremner
University of Toronto
Career Start Year
1990
Number of shared co-authors
2
Glenn S Cowley
Broad Institute of Harvard and MIT
Career Start Year
1990
Number of shared co-authors
5
Oliver B??gler
American Association for Cancer Research, Henry Ford Hospital, Ludwig Institute for Cancer Research, National Cancer Institute, Salk Institute for Biological Studies, University of Cambridge, University of Texas MD Anderson Cancer Center, Virginia Commonwealth University
Career Start Year
1990
Number of shared co-authors
1
Glenn M Marshall
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year
1989
Number of shared co-authors
10
Dirk Geerts
Amsterdam University Medical Center
Career Start Year
1989
Number of shared co-authors
1
Antonio Iavarone
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Career Start Year
1989
Number of shared co-authors
24
E Alejandro Sweet-Cordero
University of California San Francisco
Career Start Year
1989
Number of shared co-authors
12
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year
1988
Number of shared co-authors
9
Kristian Helin
The Institute of Cancer Research
Career Start Year
1988
Number of shared co-authors
16
Eldad Zacksenhaus
University of Toronto
Career Start Year
1988
Number of shared co-authors
11
Takuro Nakamura
Tohoku University Graduate School of Medicine
Career Start Year
1987
Number of shared co-authors
5
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year
1987
Number of shared co-authors
12
Tarik M??r??y
Institut de recherches cliniques de Montreal
Career Start Year
1985
Number of shared co-authors
0
Toshio Kitamura
The University of Tokyo.
Career Start Year
1984
Number of shared co-authors
3
Anna Lasorella
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Career Start Year
1984
Number of shared co-authors
9
Jorge Silvio Gutkind
Moores Cancer Center, University of California San Diego
Career Start Year
1984
Number of shared co-authors
4
Webster K Cavenee
Ludwig Institute for Cancer Research, University of California San Diego
Career Start Year
1977
Number of shared co-authors
12
Frank McCormick
Frederick National Laboratory for Cancer Research
Career Start Year
1975
Number of shared co-authors
9
Hartmut Land
University of Rochester Medical Center, Wilmot Cancer Institute
Career Start Year
1974
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Charles J Sherr
St. Jude Children's Research Hospital
Co-authored papers
96
Frederique Zindy
St. Jude Children's Research Hospital
Co-authored papers
43
Richard J Gilbertson
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers
17
Olivier Ayrault
Institut Curie, PSL Research University, CNRS UMR, INSERM
Co-authored papers
15
Giles W Robinson
St. Jude Children's Research Hospital
Co-authored papers
14
Daisuke Kawauchi
University of California-San Diego
Co-authored papers
14
Anang A Shelat
St. Jude Children's Research Hospital
Co-authored papers
12
Amar Gajjar
St. Jude Children's Research Hospital
Co-authored papers
11
Alex Look
Dana-Farber Cancer Institute
Co-authored papers
11
Jerold E Rehg
St. Jude Children's Research Hospital
Co-authored papers
11
David W Ellison
St. Jude Children's Research Hospital
Co-authored papers
9
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
8
Brent A Orr
St. Jude Children's Research Hospital
Co-authored papers
8
Mei-Ling Kuo
Kaohsiung Chang Gung Memorial Hospital
Co-authored papers
8
Marcel Kool
Hopp Children's Cancer Center (KiTZ)
Co-authored papers
7
Paul A Northcott
St Jude Children's Research Hospital
Co-authored papers
7
Taosheng Chen
St. Jude Children's Research Hospital
Co-authored papers
7
Stanley Pounds
St. Jude Children's Research Hospital.
Co-authored papers
6
Peter J McKinnon
St. Jude Children's Research Hospital
Co-authored papers
6
Jason D Weber
Washington University School of Medicine
Co-authored papers
6
Willem den Besten
Genentech Inc.
Co-authored papers
5
Mary E Hatten
The Rockefeller University
Co-authored papers
5
Suzanne J Baker
Co-authored papers
5
Charles G Eberhart
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Co-authored papers
5
Youngsoo Lee
University of Wisconsin-Madison School of Medicine and Public Health
Co-authored papers
5
Robert J Wechsler-Reya
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers
5
Tamar Uziel
AbbVie Inc.
Co-authored papers
5
Andrey Korshunov
Institute of Pathology, University Hospital Heidelberg
Co-authored papers
5
James M Olson
Clinical Research Division, Fred Hutchinson Cancer Center
Co-authored papers
4
Christopher Calabrese
St. Jude Children's Research Hospital
Co-authored papers
4
1 - 30